Cost–consequence analysis of early vs. delayed natalizumab use in highly active relapsing–remitting multiple sclerosis: a simulation study
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Neurology"
DOI: 10.1007/s00415-024-12723-4
Abstract: Natalizumab (NAT) is an established disease-modifying therapy (DMT) for highly active multiple sclerosis (MS). However, its use involves complex decision-making, often leading to initial use of lower efficacy therapies. Recently, the first biosimilar NAT was… read more here.
Keywords: multiple sclerosis; highly active; use; nat ... See more keywords
Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000005249
Abstract: Supplemental Digital Content is available in the text Objective: To evaluate the association between staging concordance, treatment sequencing, and response to neoadjuvant therapy (NAT) on the survival of patients with pancreatic ductal adenocarcinoma (PDAC). Summary… read more here.
Keywords: survival patients; adenocarcinoma; treatment; patients pancreatic ... See more keywords
Extracellular (EC) Mucin5AC (MUC5AC) detection after neoadjuvant therapy (NAT) and the risk of recurrence in resected pancreatic ductal adenocarcinoma (R-PDA).
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.4171
Abstract: 4171 Background: The clinical significance of MUC5AC glycoforms is unclear to date. Our earlier study showed the association of lower mature (MM) and immature (IM) MUC5AC in R-PDA with pathological treatment response and EC detection… read more here.
Keywords: detection; group; nat; pda ... See more keywords
Neoadjuvant Treatment in Resectable Pancreatic Cancer. Is It Time for Pushing on It?
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.914203
Abstract: Pancreatic resection still represents the only curative option for patients affected by pancreatic ductal adenocarcinoma (PDAC). However, the association with modern chemotherapy regimens is a key factor in improving the inauspicious oncological outcome. The benefit… read more here.
Keywords: neoadjuvant treatment; time; surgery; nat ... See more keywords
Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS
Sign Up to like & getrecommendations! Published in 2024 at "Cancers"
DOI: 10.3390/cancers16050910
Abstract: Simple Summary Recent observations have led to an expansion of the role of neoadjuvant treatment (NAT) as a component of a multidisciplinary approach to the treatment of pancreatic ductal adenocarcinoma (PDAC). However, some issues related… read more here.
Keywords: treatment; adenocarcinoma; response; nat ... See more keywords
Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232012625
Abstract: Neo-adjuvant therapy (NAT) is increasingly used in the clinic for the treatment of breast cancer (BC). Pathological response to NAT has been associated with improved patients’ survival; however, the current techniques employed for assessing the… read more here.
Keywords: pathological response; neo adjuvant; adjuvant therapy; breast cancer ... See more keywords
Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58060756
Abstract: Background and Objectives: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal tumors, with a 5-year overall survival rate of less than 10%. To date, curative surgical resection remains the only favorable option for… read more here.
Keywords: resectability; literature review; biochemical radiological; overall survival ... See more keywords
A Novel NAT-based Approach for Resource Load Balancing in Fog Computing Architecture
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Internet Technology"
DOI: 10.3966/160792642021052203002
Abstract: In recent years, with the rise of the internet of things technology, most devices can be connected to the internet, resulting in fewer and fewer IP addresses. Therefore, the number of applications using NAT has also increased. Coupled with… read more here.
Keywords: load balancing; computing architecture; nat; architecture ... See more keywords
Nomogram for predicting axillary pathologic complete response after neoadjuvant systemic therapy in HER2 positive and triple negative breast cancer
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Cancer"
DOI: 10.7150/jca.118908
Abstract: Purpose: With the continuous improvement in the efficacy of neoadjuvant therapy (NAT), a significant proportion of breast cancer patients initially diagnosed with pathologically confirmed axillary lymph node metastasis (pN+) may achieve ypN0 status (no residual… read more here.
Keywords: cancer; breast cancer; nat; ypn0 ... See more keywords